Search Within

Joachim Yahalom

  1. "2020"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
  3. Review (3)
  4. Correspondence (2)
  5. Editorial (2)
  6. Guidelines (2)
  7. Research Letter (1)
Groups
  1. Radiation Oncology, Department of (24)
  2. Survivorship Research (24)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Center for Hematologic Malignancies (12)
  6. Lymphoma (11)

More Groups

People
  1. Alison Moskowitz (7)
  2. Connie Batlevi (7)
  3. Steven Horwitz (7)
  4. Ariela Noy (6)
  5. Brandon Imber (6)
  6. Maria Palomba (6)

More People

Years
  1. 2020 (24)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (6)
  2. Blood (4)
  3. Blood Advances (3)
  4. Journal of Clinical Oncology (2)
  5. Leukemia and Lymphoma (2)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (7)
  3. American Society of Clinical Oncology (2)
  4. Lippincott Williams & Wilkins (2)
  5. Springer (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
    Journal Article

    Ghione, P.; Qi, S.; Imber, B. S.; Seshan, V.; Moskowitz, A.; Galasso, N.; Lunning, M.; Straus, D.; Sauter, C.; Dahi, P.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • High local control and overall survival with radiotherapy for anaplastic large cell lymphoma
    Meeting Abstract

    Wijetunga, N. A. A.; Lee, J.; Imber, B. S.; Modlin, L. A.; Ghione, P.; Khan, N.; Epstein-Peterson, Z.; Moskowitz, A. J.; Horwitz, S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • In reply to Scarpelli et al
    Correspondence

    Specht, L.; Wong, J. Y. C.; Filippi, A. R.; Dabaja, B. S.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • ILROG lymphoma mini-atlas part II, Hodgkin lymphoma
    Editorial

    Dabaja, B. S.; Ng, A. K.; Terezakis, S. A.; Plastaras, J. P.; Yunes, M.; Wilson, L. D.; Yang, J.; Gunther, J. R.; Specht, L.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Excellent outcomes with surgery or radiotherapy in the management of Castleman disease including a case of oligocentric disease
    Journal Article

    Beckham, T. H.; Yang, J. C.; Chau, K. W.; Noy, A.; Yahalom, J.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save